A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity - Clinical Trial NCTNCT06916065

Business Opportunities for NCT06916065

Connect with principal investigators, study coordinators, and key decision makers for this PHASE1 trial studying investigational therapy for Overweight, Obesity.

Clinical Trial Information

Study Sponsor

Sponsor information available

Drug/Intervention

Study intervention details available

Therapeutic Area

Obesity, Overweight

Study Phase

PHASE1

Study Status

NOT_YET_RECRUITING

NCT Number

NCTNCT06916065

Find Contact Information

Access exclusive contact details for:

• Principal investigators and sub-investigators
• Study coordinators and research staff
• Site directors and facility contacts
• Sponsor representatives and CRO partners
• Business development professionals
• Clinical operations managers

Clinical Trial Locations

This study has 3 locations across United States.

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

• Discover clinical trials before competitors
• Access exclusive contact information
• Track sponsor pipelines and opportunities
• Connect with decision makers directly
• Win more business partnerships